Cargando…
Can Neutrophil-to-Lymphocyte ratio predict the response to BCG in high-risk non muscle invasive bladder cancer?
OBJECTIVES: To evaluate the neutrophil-to-lymphocyte ratio (NLR) as a prognostic factor for response of high risk non muscle invasive bladder cancer (HRNMIBC) treated with BCG therapy. MATERIALS AND METHODS: Between March 2010 and February 2014 in a tertiary center 100 consecutive patients with newl...
Autores principales: | Racioppi, Marco, Gianfrancesco, Luca Di, Ragonese, Mauro, Palermo, Giuseppe, Sacco, Emilio, Bassi, Pier Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Urologia
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6541147/ https://www.ncbi.nlm.nih.gov/pubmed/30785697 http://dx.doi.org/10.1590/S1677-5538.IBJU.2018.0249 |
Ejemplares similares
-
ElectroMotive drug administration (EMDA) of Mitomycin C as first-line salvage therapy in high risk “BCG failure” non muscle invasive bladder cancer: 3 years follow-up outcomes
por: Racioppi, Marco, et al.
Publicado: (2018) -
The indispensable role of urinalysis for patients undergoing treatment for nonmuscle invasive bladder cancer
por: Di Gianfrancesco, Luca, et al.
Publicado: (2022) -
Improved Non-Invasive Diagnosis of Bladder Cancer with an Electronic Nose: A Large Pilot Study
por: Bassi, PierFrancesco, et al.
Publicado: (2021) -
How to reduce bacillus Calmette-Guérin discontinuation in patients with severe functional impairment
por: Di Gianfrancesco, Luca, et al.
Publicado: (2022) -
Immediate ileal ureter replacement for ureteral avulsion during ureterescopy
por: Ragonese, Mauro, et al.
Publicado: (2020)